Lin Elizabeth Yeu (CIK 1842190) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-09). Recent activity: Sell TARS (5,387 shares), Sell TARS (5,386 shares), Sell TARS (1,590 shares), Sell TARS (1,590 shares), Sell TARS (4,601 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 5,387 | $457,895 |
| 2026-09-09 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 5,386 | $484,740 |
| 2026-09-09 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 1,590 | $135,150 |
| 2026-09-09 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 1,590 | $143,100 |
| 2026-09-03 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 4,601 | $339,830 |
| 2026-09-03 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 5,387 | $430,960 |
| 2026-09-03 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 1,590 | $127,200 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 375 | $26,032 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 379 | $26,041 |
| 2026-03-19 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 390 | $26,130 |
| 2026-03-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Buy | 2,511 | $0 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Buy | 6,819 | $0 |
| 2025-12-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 2,078 | $165,201 |
| 2025-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Buy | 3,350 | $0 |
| 2025-06-17 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | Sell | 1,006 | $41,326 |
来源：SEC Form 4 申报文件 · 截至 2026-09-09